Company Launches Diabetes Program for Pharmacists

Published Online: Tuesday, February 1, 2005

Novo Nordisk is sponsoring an educational program to be developed in 2005 by the University of Pittsburgh School of Pharmacy. As a world leader in diabetes care, the company will provide an unrestricted educational grant of $500,000 for the pharmacy school to underwrite the program.

The educational program, entitled "An Elective Course in Comprehensive Diabetes Management," will be developed over several months with advice from a panel of experts in diabetes management, pharmacy education, and instructional development. The panel will set up teams of educators to instruct the trainers who will teach the course. Pharmacy schools also will be invited to send faculty members to the regional training sessions.

Schools using the program will receive instructional materials. The schools will be encouraged to work together by sharing teaching techniques, new course materials, and assessment methods. Once the initiative moves into the implementation phase, the panel will evaluate how the course is used by pharmacy schools, get student and instructor course assessments, and revise the course as necessary.



Latest Articles
This weekly video program highlights the latest in pharmacy news, product news, and more.
Propranolol is red, digoxin is blue. Your pharmacist’s heart may skip a beat if they get a valentine from you.
Health-system pharmacists can play a critical role in managing drug shortages to prevent medical errors and adverse events.
The White House is asking Congress for more than $1.8 billion in emergency funding to combat the Zika virus, which is creeping into the United States and ravaging some foreign countries.
Latest Issues
$auto_registration$
VSEO N/A